BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 25
• 29
• 30

• 

  Approvals

  GSK Wins Asthma Approval for Anti-Inflammatory Antibody

  The FDA rejected the use of Exdensur, however, for chronic rhinosinusitis with nasal polyps.

  December 17, 2025

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Artificial intelligence

  Roche Makes Good on Dealmaking Promise With $1.1B Caris Cancer Collab

  Roche CEO Thomas Schinecker said during the company’s Q3 call that it is “not done” with deals—a promise he delivered on with Tuesday’s solid tumor pact with AI-focused Caris Life Sciences.

  December 17, 2025

   · 

  1 min read

   · 

  Tristan Manalac
• Press Releases

  Compass Therapeutics to Participate in the J.P. Morgan 2026 Healthcare Conference

  December 17, 2025

   · 

  1 min read
• Press Releases

  Cytokinetics Announces NMPA Approval of MYQORZO® (aficamten) in China for Patients with Obstructive Hypertrophic Cardiomyopathy

  December 17, 2025

   · 

  8 min read
• Press Releases

  Simulations Plus Announces First Quarter Fiscal Year 2026 Earnings and Conference Call Date

  December 17, 2025

   · 

  1 min read
• 

  Autoimmune disease

  Nektar Digs Into Mid-Stage Data to Establish Alopecia Efficacy of Rezpeg

  Despite falling short of its primary Phase II objective, Nektar plans to push its T cell stimulator rezpeg into Phase III development.

  December 17, 2025

   · 

  2 min read

   · 

  Tristan Manalac
• 

  China

  BMS Forges $1B+ Antibody Alliance With Chinese Firm Harbour

  BMS is Harbour’s second powerhouse partner this year after the Chinese biotech signed a potential $4.68 billion deal with AstraZeneca in March.

  December 17, 2025

   · 

  1 min read

   · 

  Tristan Manalac
• Press Releases

  BioVaxys Announces Positive Phase 1 Clinical Study Results with Maveropepimut-S (MVP-S) in Women with Hormone Receptor Positive/HER2 Negative (HR+/HER2-) Stage II-III Breast Cancer

  December 17, 2025

   · 

  9 min read
• Press Releases

  Restart Life Announces Food Technology and Research Studies

  December 17, 2025

   · 

  6 min read
• Press Releases

  NervGen Pharma Announces Filing of Form F-10 Registration Statement with The SEC Under MJDS

  December 17, 2025

   · 

  5 min read